Grifols Operating Income 2012-2018 | GRFS

Grifols annual/quarterly operating income history and growth rate from 2012 to 2018. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Grifols operating income for the quarter ending September 30, 2018 was $0.000B, a 100% decline year-over-year.
  • Grifols operating income for the twelve months ending September 30, 2018 was $0.895B, a 13.9% decline year-over-year.
  • Grifols annual operating income for 2017 was $1.134B, a 9.09% increase from 2016.
  • Grifols annual operating income for 2016 was $1.04B, a 3.52% decline from 2015.
  • Grifols annual operating income for 2015 was $1.077B, a 5.49% decline from 2014.
Grifols Annual Operating Income
(Millions of US $)
2017 $1,134
2016 $1,040
2015 $1,077
2014 $1,140
2013 $978
2012 $849
2011 $450
Grifols Quarterly Operating Income
(Millions of US $)
Q3 2018 $0
Q2 2018 $312
Q2 2017 $314
Q1 2017 $269
Q4 2016 $267
Q3 2016 $267
Q2 2016 $250
Q1 2016 $255
Q4 2015 $276
Q3 2015 $275
Q2 2015 $259
Q1 2015 $264
Q4 2014 $171
Q3 2014 $284
Q2 2014 $237
Q1 2014 $324
Q4 2013 $209
Q3 2013 $247
Q2 2013 $266
Q1 2013 $248
Q4 2012 $188
Q3 2012 $215
Q2 2012 $216
Q1 2012 $213
Q4 2011 $796
Q3 2011 $807
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.400B $4.878B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $45.191B 30.06
Takeda Pharmaceutical (TAK) Japan $31.497B 11.65
Ionis Pharmaceuticals (IONS) United States $8.030B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.648B 10.98
Tilray (TLRY) United States $7.556B 0.00
Nektar Therapeutics (NKTR) United States $7.448B 10.68
Neurocrine Biosciences (NBIX) United States $7.208B 466.82
Sage Therapeutics (SAGE) United States $6.954B 0.00
Catalent (CTLT) United States $6.232B 26.09
United Therapeutics (UTHR) United States $5.138B 8.40
FibroGen (FGEN) United States $4.882B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.037B 12.99
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.022B 21.38
USANA Health Sciences (USNA) United States $2.385B 19.47
Endo (ENDP) Ireland $2.369B 3.63
Heron Therapeutics (HRTX) United States $2.211B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.203B 0.00
Zogenix (ZGNX) United States $1.996B 0.00
Portola Pharmaceuticals (PTLA) United States $1.990B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.953B 24.32
Xencor (XNCR) United States $1.896B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.893B 0.00
Aerie Pharmaceuticals (AERI) United States $1.800B 0.00
PTC Therapeutics (PTCT) United States $1.785B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.705B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.655B 223.61
Theravance Biopharma (TBPH) Cayman Islands $1.496B 0.00
Corcept Therapeutics (CORT) United States $1.307B 19.19
TherapeuticsMD (TXMD) United States $1.299B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.242B 0.00
Esperion Therapeutics (ESPR) United States $1.176B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.985B 0.00
Tricida (TCDA) United States $0.961B 0.00
Radius Health (RDUS) United States $0.860B 0.00
ImmunoGen (IMGN) United States $0.833B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.587B 0.00
Karyopharm Therapeutics (KPTI) United States $0.566B 0.00
ChemoCentryx (CCXI) United States $0.560B 44.36
Siga Technologies (SIGA) United States $0.560B 0.00
Flexion Therapeutics (FLXN) United States $0.547B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.540B 0.00
GlycoMimetics (GLYC) United States $0.511B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.510B 30.09
Collegium Pharmaceutical (COLL) United States $0.498B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.479B 0.00
Forty Seven (FTSV) United States $0.476B 0.00
Odonate Therapeutics (ODT) United States $0.447B 0.00
Aptorum Group (APM) China $0.428B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.392B 0.00
Translate Bio (TBIO) United States $0.386B 0.00
Lannett Co Inc (LCI) United States $0.385B 3.58
Akebia Therapeutics (AKBA) United States $0.374B 0.00
ArQule (ARQL) United States $0.361B 0.00
HARPOON THERAPT (HARP) United States $0.350B 0.00
CASI Pharmaceuticals (CASI) United States $0.345B 0.00
KalVista Pharmaceuticals (KALV) United States $0.345B 0.00
Concert Pharmaceuticals (CNCE) United States $0.342B 0.00
Tyme Technologies (TYME) United States $0.330B 0.00
Dermira (DERM) United States $0.314B 0.00
Minerva Neurosciences (NERV) United States $0.306B 0.00
OptiNose (OPTN) United States $0.297B 0.00
Majesco Entertainment (PTE) United States $0.295B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.289B 10.76
Verrica Pharmaceuticals (VRCA) United States $0.286B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.284B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.275B 0.00
Aclaris Therapeutics (ACRS) United States $0.268B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Mast Therapeutics (SVRA) United States $0.236B 0.00
Opexa Therapeutics (ACER) United States $0.231B 0.00
IMV INC (IMV) Canada $0.217B 0.00
Dova Pharmaceuticals (DOVA) United States $0.216B 0.00
Aratana Therapeutics (PETX) United States $0.213B 0.00
Affimed (AFMD) Germany $0.212B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.211B 0.00
Calithera Biosciences (CALA) United States $0.210B 0.00
Rafael Holdings (RFL) United States $0.207B 0.00
Xeris Pharmaceuticals (XERS) United States $0.206B 0.00
Aldeyra Therapeutics (ALDX) United States $0.203B 0.00
MEI Pharma (MEIP) United States $0.198B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.197B 0.00
ElectroCore (ECOR) United States $0.196B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.189B 0.00
Recro Pharma (REPH) United States $0.188B 0.00
Molecular Templates (MTEM) United States $0.175B 0.00
Redhill Biopharma (RDHL) Israel $0.173B 0.00
Zafgen (ZFGN) United States $0.173B 0.00
Ardelyx (ARDX) United States $0.163B 0.00
AgeX Therapeutics (AGE) United States $0.162B 0.00
Nature's Sunshine Products (NATR) United States $0.159B 0.00
Aquestive Therapeutics (AQST) United States $0.157B 0.00
Ocular Therapeutix (OCUL) United States $0.154B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.153B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.150B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.148B 0.00
Adherex Technologies (FENC) United States $0.143B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.139B 0.00
Neon Therapeutics (NTGN) United States $0.136B 0.00
Jounce Therapeutics (JNCE) United States $0.133B 0.00
MediWound (MDWD) Israel $0.129B 0.00
Cardiome Pharma (CORV) Canada $0.125B 0.00
ProNAi Therapeutics (SRRA) Canada $0.120B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.119B 0.00
DURECT (DRRX) United States $0.119B 0.00
China SXT Pharmaceuticals (SXTC) China $0.116B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.115B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.101B 0.00
Champions Oncology (CSBR) United States $0.098B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 0.00
Natural Alternatives (NAII) United States $0.083B 8.13
Nivalis Therapeutics (ALPN) United States $0.083B 0.00
Iterum Therapeutics (ITRM) Ireland $0.081B 0.00
Infinity Pharmaceuticals (INFI) United States $0.078B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.076B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.075B 0.00
Melinta Therapeutics (MLNT) United States $0.075B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.074B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.074B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.071B 0.00
Neos Therapeutics (NEOS) United States $0.071B 0.00
Immune Design (IMDZ) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.068B 0.00
Forward Pharma (FWP) Denmark $0.063B 0.00
Otonomy (OTIC) United States $0.061B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.061B 0.00
Avenue Therapeutics (ATXI) United States $0.061B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
KemPharm (KMPH) United States $0.056B 0.00
CTI BioPharma (CTIC) United States $0.054B 0.00
Mannatechorporated (MTEX) United States $0.045B 0.00
Genocea Biosciences (GNCA) United States $0.043B 0.00
BioLineRx (BLRX) Israel $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.042B 0.00
Achaogen (AKAO) United States $0.041B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.041B 0.00
ContraFect (CFRX) United States $0.037B 0.00
Capnia (SLNO) United States $0.036B 0.00
Lipocine (LPCN) United States $0.036B 0.00
Heat Biologics (HTBX) United States $0.034B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
NOVAN INC (NOVN) United States $0.030B 0.00
NanoViricides (NNVC) United States $0.029B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.028B 0.00
PharmAthene (ALT) United States $0.025B 0.00
IsoRay (ISR) United States $0.024B 0.00
ESSA Pharma (EPIX) Canada $0.024B 0.00
Can-Fite Biopharma (CANF) Israel $0.023B 0.00
Biomerica (BMRA) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Onconova Therapeutics (ONTX) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Trillium Therapeutics (TRIL) Canada $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.014B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Shineco (TYHT) China $0.011B 1.25
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Regulus Therapeutics (RGLS) United States $0.009B 0.00
Intellipharmaceutics (IPCI) Canada $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00